跳至主要内容
临床试验/CTRI/2025/03/081505
CTRI/2025/03/081505尚未招募不适用

A study to evaluate the effectiveness of homoeopathic medicine acid phosphoricum 30 c potency versus acid phosphoricum mother tincture in management of diabetes mellitus type 2

Dr NiteshKumar M Babariya1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年3月24日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Disappearance Of The Clinical Features Of Type 2 Diabetes Mellitus, But Recurrence Of The Same With Less Intensity, With General Well-Being Of Patient,

研究概览

简要总结

Diabetes mellitus (DM) is a growing global health concern and a leading cause of mortality, particularly in developed nations. India has seen a significant rise in diabetes cases, with current estimates exceeding 77 million patients. Projections indicate that by 2025, India will have the highest number of diabetics worldwide. Uncontrolled diabetes leads to severe complications, including blindness, amputations, and kidney failure.

Conventional treatments, including insulin and oral hypoglycemic agents, have effectively managed diabetes but often come with adverse effects such as hypoglycemia, liver toxicity, gastrointestinal issues, and metabolic imbalances. Given the increasing prevalence of diabetes, alternative approaches like homeopathy are being explored.

Homeopathy, based on principles of individualization and holistic healing, aims to treat the patient rather than just the disease. This study evaluates the effectiveness of Acid Phosphoricum 30C potency versus Acid Phosphoricum mother tincture in managing Type 2 Diabetes Mellitus. By assessing their impact on blood sugar regulation and overall patient well-being, this research aims to explore homeopathy as a complementary or alternative therapeutic option for diabetes management.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Samples aged from 30 to 80 years are included.
  • Subjects of both sexes, irrespective of socio-economic status are included.
  • Diagnostic criteria are based mainly on clinical presentation and blood & urine investigation are included.

排除标准

  • Patients Below 30 And Above 80 Years Of Age With Type 2 Diabetes Mellitus Are Excluded.
  • Diabetes Mellitus With Complications Like Gangrene, Amputation And Retinal Damage Etc Are Excluded.
  • Diabetes Associated With Other Systemic Diseases Which Are On Active Treatment Are Excluded.
  • Those Not Willing To Participate In The Study.
  • Pregnant And Lactating Mothers.

结局指标

主要结局

Disappearance Of The Clinical Features Of Type 2 Diabetes Mellitus, But Recurrence Of The Same With Less Intensity, With General Well-Being Of Patient,

时间窗: Baseline (Week 0): Record initial clinical features and HbA1c levels. | Week 4: Assess early symptom changes and well-being. | Week 8: Evaluate symptom progression and recurrence. | Week 12: Review treatment response and general health. | Week 24: Assess long-term improvement and relapse. | Follow-up intervals may be adjusted based on patient response.

次要结局

  • Glycemic Variability Monitoring fluctuations in blood glucose levels over time.(Baseline (Week 0) Record pre-treatment fasting & postprandial glucose levels.)

研究者

发起方
Dr NiteshKumar M Babariya
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr NiteshKumar M Babariya

Rajkot Homoeopathic Medical College

研究点 (1)

Loading locations...

相似试验